Mike Mensinger, Chief Product Officer at Beta Bionics, Inc. (BBNX), bought 59,032 shares at $17.00 ($567K) on 2025-01-31, disclosed to the SEC on 2025-02-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 15,107 | $0 | 0.0% |
| 2 | $0.02 | 10,575 | $212 | 0.0% |
| 3 | $17.00 | 33,350 | $567K | 100.0% |
| Total | $9.61 avg | 59,032 | $567K | 100% |
| Filing → |
| BBNX | SELL | 2026-06-03 | $55K | — | Filing → |
| BBNX | SELL | 2026-03-03 | $13K | — | Filing → |
| BBNX | SELL | 2026-01-07 | $66K | — | Filing → |